Synthesis, cytotoxicity, and antileishmanial activity of N,N′-disubstituted ethylenediamine and imidazolidine derivatives

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1723-1730

  De Carvalho, Gustavo S G ^a   Machado, Patrícia A ^a   De Paula, Daniela T S ^a   Coimbra, Elaine S ^a   Da Silva, Adilson D ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Antileishmanial activity; Ethylenediamines; Imidazolidines; Leishmania

Indexed keywords

1,2 BIS(4 METHOXYBENZYL)ETHYLENEDIAMINE; 1,3 BIS(4 METHOXYBENZYL)IMIDAZOLIDINE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ETHYLENEDIAMINE DERIVATIVE; IMIDAZOLIDINE DERIVATIVE; POLYAMINE; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; ETHYLENEDIAMINE;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; IC 50; IN VITRO STUDY; LEISHMANIA; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROMASTIGOTE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL SURVIVAL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; PARASITOLOGY; SYNTHESIS;

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; MAMMALIA;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; ETHYLENEDIAMINES; IMIDAZOLIDINES; LEISHMANIA; LEISHMANIA MAJOR; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MODELS, CHEMICAL; MOLECULAR STRUCTURE;

EID: 78349278469     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.176     Document Type: Article

References (26)

1. Santos, D.O., Coutinho, C.E., Madeira, M.F., Bottino, C.G., Vieira, R.T., Nascimento, S.B., Bernardino, A., Bourguignon, S.C., Corte-Real, S., Pinho, R.T., Rodrigues, C.R., and Castro, H.C. (2008) Leishmaniasis treatment - a challenge that remains: a review. Parasitol. Res. 103, 1-10.
2. Cruz, A.K, De Toledo, J.S., Falade, M., Terrão, M.C., Kamchonwongpaisan, S., Kyle, S., and Uthaipibull, C. (2009) Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review. Curr. Drug Targets 10, 178-192.
3. Singh, R.K., Pandey, H.P., and Sundar, S. (2006) Visceral leishmaniasis (kala-azar): challenges ahead. Indian J. Med. Res. 123, 331-344. (Pubitemid 43905573)
4. Vieira, N.C., Herrenknecht, C., Vacus, J., Fournet, A., Bories, C., Figadère, B., Espindola, L.S., and Loiseau, P.M. (2008) Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. Biomed. Pharmacother. 62, 684-689.
5. Del Olmo, E., Alves, M., Lopéz, J.L., Inchaustti, A., Yaluff, G., De Arias, A.R., and San Feliciano, A. (2002) Leishmanicidal activity of some aliphatic diamines and amino-alcohols. Bioorg. Med. Chem. Lett. 12, 659-662. (Pubitemid 34158916)
6. Rebollo, O., Del Olmo, E., Ruiz, G., Lopéz, J.L., Giménez, A., and San Feliciano, A. (2008) Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives. Bioorg. Med. Chem. Lett. 18, 184-187.
7. Bacchi, C.J. and Yarlett, N. (2002) Polyamine metabolism as chemotherapeutic target in protozoan parasites. Mini Rev. Med. Chem. 2, 553-563.
8. Casero, R.A., Jr. and Woster, P.M. (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44, 1-26.
9. Nieper, H.A. (1966) Experimental tests of new carcinostatic compounds in HeLa cells. Arztl. Forsch. 20, 18-21.
10. Schoenenberger, H., Adam, A., and Adam, D. (1966) The action of aminomethylating carcinostatics on experimental tumors. Arztl. Forsch. 16, 734-738.
11. Coimbra, E.S., Almeida, C.G., Júnior, W.V., Dos Reis, R.C., De Almeida, A.C., Forezi, L.S., De Almeida, M.V., and Le Hyaric, M. (2008) Antileishmanial activity of aldonamides and N-acyl-diamine derivatives. TheScientificWorldJOURNAL. 8,752-756.
12. Da Costa, C.F., Coimbra, E.S., Braga, F.G., dos Reis, R.C., da Silva, A.D., and de Almeida, M.V. (2009) Preparation and antileishmanial activity of lipophilic N-alkyl diamines. Biomed. Pharmacother. 63, 40-42.
13. Caterina, M.C., Perillo, I.A., Boiani, L., Pezaroglo, H., Cerecetto, H., González, M., and Salerno, A. (2008) Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships. Bioorg. Med. Chem. 16, 2226-2234. (Pubitemid 351380953)
14. Sharma, V. and Khan, M.S. (2001) Synthesis of novel tetrahydroimidazole derivatives and studies for their biological properties. Eur. J. Med. Chem. 36, 651-658. (Pubitemid 32964735)
15. Herrmann, H.O. and Gercken, G. (1982) Metabolism of 1-0-[1'-14C] octadecyl-sn-glycerol in Leishmania donovani promastigotes. Ether lipid synthesis and degradation of the ether bond. Mol. Biochem. Parasitol. 5, 65-76.
16. Basselin, M. and Robert-Gero, M. (1998) Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania. Parasitol. Res. 84, 78-83. (Pubitemid 28097631)
17. Heby, O., Roberts, S.C., and Ulman, B. (2003) Polyamine biosynthetic enzymes as drug targets in parasitic protozoa. Biochem. Soc. Trans. 31, 415-419. (Pubitemid 36520688)
18. Billman, J.H., Chen Ho, J.Y., and Caswell, L.R. (1952) The formation of solid derivatives of aldehydes. I. 2-Substituted-1,3-Bis(p-methoxybenzyl)- tetrahydroimidazoles. J. Org. Chem. 17, 1375-1378.
19. 3, MeOPh), 6.89 (d, 4H, 4CH, J = 8), 7.64 (d, 4H, 4CH). 2-Substituted-1,3-Bis(p-methoxybenzyl) imidazolidines 5-11. Imidazolidine derivatives were obtained by reaction of the compound 4 (0.01 mol) and aldehydes (0.01 mol) or aqueous formaldehyde (37%, excess) in ethanol (10 mL) under 70°C by 1 h. Compounds 6-11 were precipitated by cooling the mixture. Compound 5 was obtained by extraction in oil form.
20. Warren, L.G. (1960) Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate. J. Parasitol. 46, 529-539.
21. Rodrigues, F.H., Afonso-Cardoso, S.R., Gomes, M.A.B., Beletti, M.E., Rocha, A., Guimarães, A.H.B., Candeloro, I., and de Souza, M.A. (2006) Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis. Vet. Parasitol. 139, 37-46. (Pubitemid 43775780)
22. MBongo, N., Loiseau, P.M., Lawrence, F., Bories, C., Craciunescu, D.G., and Robert-Gero, M. (1997) Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani. Acta Trop. 70, 239-245.
23. Morais-Teixeira, E., Carvalho, A.S., Costa, J.C.S., Duarte, S.L., Mendonça, J.S., Boechat, N., and Rabello, A. (2008) In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis. Mem. Inst. Oswaldo Cruz 103, 358-362.
24. Santos, A.O., Ueda-Nakamura, T., Dias Filho, B.P., Veiga Junior, V.F., Pinto, A.C., and Nakamura, C.V. (2008) Effect of Brazilian copaiba oils on Leishmania amazonensis. J. Ethnopharmacol. 120, 204-208.
25. Braga, F.G., Coimbra, E.S., de Oliveira Matos, M., Lino Carmo, A.M., Cancio, M.D., and da Silva, A.D. (2007) Synthesis and biological evaluation of some 6-substituted purines. Eur. J. Med. Chem. 42, 530-537. (Pubitemid 46541604)
26. Escobar, P., Matu, S., Marques, C., and Croft, S.L. (2002) Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop. 81, 151-157. (Pubitemid 34093805)